EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 26 filers reported holding EVOKE PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,000 | -16.7% | 32,000 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $18,000 | -53.8% | 32,000 | 0.0% | 0.01% | -56.2% |
| Q3 2021 | $39,000 | -7.1% | 32,000 | 0.0% | 0.02% | -11.1% |
| Q2 2021 | $42,000 | -28.8% | 32,000 | 0.0% | 0.02% | -41.9% |
| Q1 2021 | $59,000 | -28.9% | 32,000 | 0.0% | 0.03% | -38.0% |
| Q4 2020 | $83,000 | -44.7% | 32,000 | 0.0% | 0.05% | -55.4% |
| Q3 2020 | $150,000 | +32.7% | 32,000 | 0.0% | 0.11% | +25.8% |
| Q2 2020 | $113,000 | +205.4% | 32,000 | 0.0% | 0.09% | +134.2% |
| Q1 2020 | $37,000 | -28.8% | 32,000 | 0.0% | 0.04% | -5.0% |
| Q4 2019 | $52,000 | +79.3% | 32,000 | -3.5% | 0.04% | +66.7% |
| Q3 2019 | $29,000 | +38.1% | 33,165 | 0.0% | 0.02% | +33.3% |
| Q2 2019 | $21,000 | -12.5% | 33,165 | 0.0% | 0.02% | -18.2% |
| Q1 2019 | $24,000 | -70.7% | 33,165 | 0.0% | 0.02% | -75.6% |
| Q4 2018 | $82,000 | – | 33,165 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 175,000 | $448,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $1,280,000 | 0.22% |
| PRECEPT MANAGEMENT LLC | 95,000 | $243,000 | 0.15% |
| Family Management Corp | 10,425 | $27,000 | 0.02% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 400,000 | $1,024,000 | 0.01% |
| Acrospire Investment Management LLC | 2,489 | $6,000 | 0.01% |
| A.R.T. Advisors, LLC | 15,413 | $39,000 | 0.00% |
| NORTHERN TRUST CORP | 29,214 | $75,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 23,048 | $59,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $0 | 0.00% |